Satoshi Taira

President at Titan, Inc. (Japan)

64 year

Health Technology

Technology Services

Profile

Satoshi Taira is currently the President & Representative Director at Titan, Inc. (Japan) and Tella Pharma, Inc. He was previously the President & Representative Director at tella, Inc. from 2019 to 2021.

Satoshi Taira active positions

Companies	Position	Start
Titan, Inc. (Japan) Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan.	President	-
Tella Pharma, Inc. Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan.	President	2019-04-30

All active positions of Satoshi Taira

Former positions of Satoshi Taira

Companies	Position	End
TELLA, INC.	President	2021-07-19

See the detail of Satoshi Taira's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Satoshi Taira's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Titan, Inc. (Japan) Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan.	Technology Services
Tella Pharma, Inc. Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan.	Health Technology
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology

See company connections

Stock Market
Insiders
Satoshi Taira